N/A UNCHANGED Last Price Updated: Add to My Watchlist
Auxilium Pharmaceuticals Up 80.6% Since SmarTrend Uptrend Call (AUXL)
February 13, 2015
Can Pharma ETFs Continue Their Uptrend In 2015?
January 11, 2015
The worst of the patent cliff is over for the pharma sector which is slowly but steadily recovering from the impact of genericization. The NYSE ARCA Pharmaceutical Index is up 19.3% over the last...
From Blogs - TalkMarkets
Auxilium Pharmaceuticals: 52-Week High Recently Eclipsed (AUXL)
January 07, 2015
Hottest Healthcare Stocks Now – SNY WX AUXL HTWR
January 06, 2015
Auxilium Pharmaceuticals Up 71.7% Since SmarTrend Uptrend Call (AUXL)
December 31, 2014
Auxilium Pharmaceuticals Shares Up 69.2% Since SmarTrend's Buy Recommendation (AUXL)
December 24, 2014
Auxilium Pharmaceuticals Up 68.6% Since SmarTrend Uptrend Call (AUXL)
December 02, 2014
Auxilium Pharmaceuticals Shares Up 69.5% Since SmarTrend's Buy Recommendation (AUXL)
November 25, 2014
Auxilium Pharmaceuticals: The Winning Streak Continues (AUXL)
November 21, 2014
Auxilium Pharmaceuticals (AUXL) gains on Endo deal
November 19, 2014
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) shares hiked 0.7% to $32.92, after the company and Endo International announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements...
Hottest Healthcare Stocks Now – CLDX AVNR AUXL AZN
November 18, 2014
Auxilium Pharmaceuticals Earnings Review: 18 Days after Announcement Shares Up 0.9% (AUXL)
November 17, 2014
Hottest Healthcare Stocks Now – ENDP LGND MRK AUXL
November 03, 2014
Scuttled ‘inversion’ deals pile up in wake of Treasury rules
October 27, 2014
Tax ‘inversions’ are imploding in the wake of rules announced in September by the Treasury Department. Some companies have adjusted their plans, but investors aren’t convinced that all pending deals...
Drug ETFs Attractive Buys On Pullback
October 22, 2014
The market pullback was due to a combination of factors that ranged from the Ebola scare to high valuations to falling oil prices to ...
Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Now Approved For The Concurrent Treatment Of Up To Two Affected Joints In The Same Hand In Dupuytren's Contracture Patients
October 20, 2014
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug ...
Auxilium Pharmaceuticals Shares Up 57.3% Since SmarTrend's Buy Recommendation (AUXL)
October 10, 2014
UPDATE: Mizuho Securities Downgrades Auxilium Pharmaceuticals
October 10, 2014
Mizuho Securities downgraded Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) from Buy to Neutral and lowered its price target from $37 ...